Search Autoimmune Association
Share this article
Autoimmune Eye Disease Blog

YOU helped convince the FDA to approve the first and only medicine to treat TED.

Last month we needed your help, you answered the call, and now there is new hope for the autoimmune disease community.

The FDA was holding a hearing to determine if it would approve the first and only medicine to treat Thyroid Eye Disease (TED), a rare autoimmune eye condition that can severely impair vision. AARDA, along with many other patient advocacy organizations attended to make the case for our community. We asked for your personal stories, experiences, and perspectives on living with TED to share with the FDA. Our statement acknowledged the suffering caused by TED and the life-changing importance of a potential new treatment.  We heard your comments and they were compelling. Autoimmune Association was honored to deliver your words, in your voice, in our statement to the FDA. 

Last week the FDA approved that breakthrough drug, TEPEZZA, with the potential to prevent permanent eye damage, pain, and disfigurement.

As autoimmune diseases cluster in people and in families, this is a breakthrough for the entire autoimmune disease community. This drug is the start of better treatment and improved quality of life for people whose vision is threatened by TED. As we’ve seen with other medications, this can also lead the way for new treatments for other autoimmune diseases that impact the eyes.

Thank you to everyone who shared their stories, their struggles, and their journeys with us. With your help, there is new hope.

 

[button title=”Read the Press Release” link=”https://ir.horizontherapeutics.com/news-releases/news-release-details/fda-approves-tepezzatm-teprotumumab-trbw-treatment-thyroid-eye” target=”_blank” align=”” icon=”” icon_position=”” color=”blue” font_color=”white” size=”2″ full_width=”” class=”” download=”” rel=”” onclick=””]

 

Those who participated were contacted through ARNet. With permission given to Autoimmune Association to contact them and share their stories.

 

[button title=”Learn more about ARNet” link=”https://autoimmune.org/who-we-help/patients/arnet/” target=”_blank” align=”” icon=”” icon_position=”” color=”blue” font_color=”white” size=”2″ full_width=”” class=”” download=”” rel=”” onclick=””]

 

Share this article

Join our email list

Receive the latest blog articles, news, and more right to your inbox!

Related articles you might be interested in

Autoimmune Association Image Do Not Touch

New Scorecard Highlights Access Barriers Faced by People Living with Autoimmune Diseases

Let My Doctors Decide – an initiative of the Autoimmune Association to raise awareness of insurer access restrictions – has rolled out a...
Autoimmune Association Image Do Not Touch

How Can We Curb the Autoimmune Epidemic? New Paper Suggests a Path Forward

Both autoimmunity and autoimmune diseases are dramatically increasing in many parts of the world, notes Dr. Frederick Miller, a current NIH Scientist Emeritus...
Autoimmune Association Image Do Not Touch

President Biden Signs Legislation that Includes Language to Establish an Office of Autoimmune Disease Research

December 29, 2022 — The Autoimmune Association applauds Congress for passing and President Biden for signing the omnibus federal spending bill that includes...
Autoimmune Association Image Do Not Touch

Remembering Eula Hoover

Today, December 17, we celebrate the birthday of Eula Hoover, a founding member of the American Autoimmune Related Diseases Association (AARDA, the former...

Find more resources on autoimmunity

Learn more about autoimmunity, diagnosis tips, how to find a physician, and more.